Correlation of topoiosomerase II inhibitor chemosensitivity and p53 variants in human non-small cell lung cancer cells
碩士 === 國立臺灣師範大學 === 生命科學研究所 === 95 === Since topoisomerase II are active in cancer cells, the two inhibitors, ellipticine and etoposide (VP-16), are commonly used in cancer therapy by interrupting DNA replication during mitosis. It is also known that tumor suppressor p53 plays critical role in cell...
Main Authors: | Chai-Wei Lin, 林佳薇 |
---|---|
Other Authors: | Kang Fang |
Format: | Others |
Language: | zh-TW |
Published: |
2007
|
Online Access: | http://ndltd.ncl.edu.tw/handle/83164636343082713790 |
Similar Items
-
Phenotypic variations and chemosensitivity in small cell lung cancer
by: Furon, Emeline
Published: (2008) -
Expression of TP53 isoforms p53β or p53γ enhances chemosensitivity in TP53(null) cell lines.
by: Elisabeth Silden, et al.
Published: (2013-01-01) -
Deguelin Enhances Chemosensitivity of Non-Small Cell Lung Cancer Cells
by: Yi-Fang Yang, et al.
Published: (2006) -
A study of p53-mediated chemosensitivity
by: Gillotin, SeÌbastien
Published: (2007) -
In HPV-Positive HNSCC Cells, Functional Restoration of the p53/p21 Pathway by Proteasome Inhibitor Bortezomib Does Not Affect Radio- or Chemosensitivity
by: Steve Seltzsam, et al.
Published: (2019-03-01)